Apple Tree Partners

Founded in 1999, Apple Tree specializes in startup, early venture and growth capital investments. Based in New York, the firm invests in therapeutics and medical devices. Companies in its portfolio include Braeburn Pharmaceuticals, a developer of solutions for people living with opioid addiction; Stoke Therapeutics, which focuses on gene expression to treat a wide array of diseases caused by genetic insufficiency; and ROX Medical, a late-stage medical device company developing a device treatment of drug resistant hypertension.
Read more about Apple Tree at